Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
Travere Therapeutics, Inc. (RTRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
SC 13G/A
| BlackRock Inc. reports a 10.3% stake in Travere Therapeutics, Inc. |
| 05/15/2023 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in TRAVERE THERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 6.2% stake in TRAVERE THERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G/A
| MACQUARIE GROUP LTD reports a 5.5% stake in Travere Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 10% stake in TRAVERE THERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 5.5% stake in Travere Therapeutics Inc. |
| 02/09/2023 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 4% stake in Travere Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 3% stake in Travere Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 9.2% stake in TRAVERE THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G/A
| MACQUARIE GROUP LTD reports a 6.2% stake in Travere Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Deep Track Capital, LP reports a 4% stake in TRAVERE THERAPEUTICS, INC. |
| 02/10/2022 |
SC 13G/A
| JANUS HENDERSON GROUP PLC reports a 6.6% stake in TRAVERE THERAPEUTICS, INC. |
| 02/10/2022 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 2.1% stake in Travere Therapeutics, Inc. |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 6.3% stake in Travere Therapeutics Inc. |
| 02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Consonance Capital Management LP reports a 5.4% stake in Retrophin, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Broadfin Capital, LLC reports a 0% stake in Retrophin, Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/10/2020 |
SC 13G/A
| BlackRock Inc. reports a 10.1% stake in RETROPHIN INC |
| 08/12/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 7.9% stake in Retrophin, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Consonance Capital Management LP reports a 9.8% stake in Retrophin, Inc. |
|
|
|